Provided by Tiger Trade Technology Pte. Ltd.

Avalo Therapeutics Inc

16.64
+0.06000.36%
Volume:270.11K
Turnover:4.56M
Market Cap:892.40M
PE:-3.77
High:17.19
Open:16.97
Low:16.56
Close:16.58
52wk High:24.27
52wk Low:9.84
Shares:53.63M
Float Shares:40.15M
Volume Ratio:0.32
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4100
EPS(LYR):-5.8400
ROE:-36.27%
ROA:-18.50%
PB:1.99
PE(LYR):-2.85

Loading ...

Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 23

Avalo CMO Mittie Doyle disposes 3,000 shares for $56,280

Reuters
·
May 20

Avalo Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $35 From $40

THOMSON REUTERS
·
May 14

U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology

Reuters
·
May 14

Avalo Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Avalo Therapeutics Q1 net loss widens on increased R&D spend

Reuters
·
May 13

Earnings Flash (AVTX) Avalo Therapeutics Posts Q1 Loss $0.98 a Share, vs. FactSet Est of $1.03 Loss

MT Newswires Live
·
May 13

Avalo net loss widens to $19.63 million in Q1 FY26

Reuters
·
May 13

Avalo Therapeutics: Current Cash, Cash Equivalents, and Short-Term Investments Expected to Fund Operations Into 2029

THOMSON REUTERS
·
May 13

Avalo Therapeutics Q1 Operating Expenses USD 20.901 Million

THOMSON REUTERS
·
May 13

Avalo Therapeutics Q1 EPS USD -0.98

THOMSON REUTERS
·
May 13

Press Release: Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates

Dow Jones
·
May 13

U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla

Reuters
·
May 11

Avalo Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview

Reuters
·
May 08

Avalo CFO Christopher Sullivan disposes of common shares worth $1.03 million

Reuters
·
May 08

Avalo CMO Mittie Doyle disposes 108,234 shares worth $2.28 million

Reuters
·
May 08

Avalo Chief Legal Officer Paul Varki disposes of common shares worth $1.49 million

Reuters
·
May 08

Avalo Therapeutics director Mitchell Chan sells 3,167 shares for $72,478.96

Reuters
·
May 08

Guggenheim Keeps Their Buy Rating on Avalo Therapeutics (AVTX)

TIPRANKS
·
May 07

Stifel Nicolaus Reaffirms Their Buy Rating on Avalo Therapeutics (AVTX)

TIPRANKS
·
May 06